Overview
Scott Tagawa is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Tagawa is rated as an Advanced provider by MediFind in Prostatectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Orchiectomy, and Prostatectomy.
His clinical research consists of co-authoring 219 peer reviewed articles and participating in 24 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles and participated in 1 clinical trial in the study of Prostatectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
520 E 70th St, Cornell Hematology Oncolog, New York, NY 10021
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
24 Clinical Trials
Howard Scher is an Oncologist in New York, New York. Dr. Scher is rated as a Distinguished provider by MediFind in Prostatectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Orchiectomy, and Prostatectomy.
Philip Kantoff is an Oncologist in New York, New York. Dr. Kantoff is rated as a Distinguished provider by MediFind in Prostatectomy. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Orchiectomy, and Prostatectomy.
Northwell Health Physician Partners Smith Institute For Urology At Lenox Hill
Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as a Distinguished provider by MediFind in Prostatectomy. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Familial Prostate CancerDr. Tagawa isElite. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Tagawa isElite. Learn about Prostate Cancer.
- Distinguished
- Bladder CancerDr. Tagawa isDistinguished. Learn about Bladder Cancer.
- Penile CancerDr. Tagawa isDistinguished. Learn about Penile Cancer.
- Renal Cell Carcinoma (RCC)Dr. Tagawa isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Tagawa isDistinguished. Learn about Urothelial Cancer.
- Advanced
- ChoriocarcinomaDr. Tagawa isAdvanced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Tagawa isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Tagawa isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Tagawa isAdvanced. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Tagawa isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder Cancer
- Experienced
- Adult Soft Tissue SarcomaDr. Tagawa isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Tagawa isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Tagawa isExperienced. Learn about Anemia.
- Bone TumorDr. Tagawa isExperienced. Learn about Bone Tumor.
- Caffey DiseaseDr. Tagawa isExperienced. Learn about Caffey Disease.
- DehydrationDr. Tagawa isExperienced. Learn about Dehydration.
